Results 131 to 140 of about 518,484 (319)
RELMβ/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract
David Artis +12 more
openalex +2 more sources
Chronic PET‐Microplastic Exposure: Disruption of Gut–Liver Homeostasis and Risk of Hepatic Steatosis
Chronic exposure to environmentally relevant PET microplastics disrupts gut–liver homeostasis, leading to hepatic steatosis, early fibrosis, and altered gut microbiota. These effects signal metabolic imbalance and gut–liver axis impairment, emphasizing chronic microplastic ingestion as an emerging environmental health risk linked to non‐communicable ...
Surye Park +5 more
wiley +1 more source
FPD‐GELNs co‐deliver Su and bioactive components. This active‐passive dual‐targeting strategy suppresses the progression of RCC through the following mechanisms: 1) inhibition of the PI3K‐Akt signaling pathway; 2) downregulation of ABCB1/P‐gp to enhance the chemosensitivity of RCC to Su; and 3) reprogramming of macrophages toward M1 polarization and ...
Haoyu Xu +8 more
wiley +1 more source
Sepsis and the diverse organ-gastrointestinal tract axis. [PDF]
Wang JDJ, Suan E, Li SS, Shelat VG.
europepmc +1 more source
Biodegradable Adhesive Systems for Bio‐Integrated Applications
Biodegradable adhesives provide temporary yet reliable adhesion while degrading into safe, non‐toxic by‐products under physiological or environmental conditions. This review summarizes recent developments in physical and chemical adhesion mechanisms—including hydrogen bonding, catechol chemistry, amine‐carboxyl coupling, and emerging diazirine and urea
Won Bae Han +6 more
wiley +1 more source
Hydrogel-based experimental models of the gastrointestinal tract. [PDF]
Sieders M, Candry P, El Aidy S.
europepmc +1 more source
Enteric neurons express Steel factor-lacZ transgene in the murine gastrointestinal tract
Shigeko Torihashi +4 more
openalex +1 more source
Recent Achievements in Stem Cell Therapy for Pediatric Gastrointestinal Tract Disease [PDF]
Sun Hwan Bae
openalex +1 more source
The development of a novel engineered strain of Lactiplantibacillus plantarum (Lp) is reported that can produce bacterial extracellular vesicles (BEVs) at >60‐fold higher yields than the unmodified parental strain. These Lp BEVs retain therapeutic bioactivity as validated in a mouse model of dextran sodium sulfate‐induced colitis.
Nicholas H Pirolli +16 more
wiley +1 more source

